FDA Label for Pleo Oku

View Indications, Usage & Precautions

Pleo Oku Product Label

The following document was submitted to the FDA by the labeler of this product Sanum Kehlbeck Gmbh & Co. Kg. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Indications



For temporary relief of acute diarrhea.


Ingredients



30 mL Okoubaka aubrevillei 2X in a base of purified water, ethanol (70%).


Tamper Evident



Do not use this product if tamper-evident seal on base of bottle cap is missing or broken or if imprinted security strip on carton is torn.


Acute



5 drops, every ½ to 1 hour;


Chronic



5 drops, 1-3 times daily.


Warning



lf symptoms persist more than a few days, contact a licensed practitioner. As with any other drug, if you are pregnant or nursing a baby, seek the advice of a health care professional before using this product.


Principal Display Panel - 30 Ml Label



Pleo™ Oku DROPS 2X

Homeopathic Antidiarrheal Medicine

Indications: For temporary relief of acute diarrhea.

1 fl oz (30 mL)

DOSAGE: Acute: 5 drops every ½ to 1 hour; Chronic: 5 drops, 1–3 times daily. WARNING:
If symptoms persist more than a few days, contact a licensed practitioner. As with any other
drug, if you are pregnant or nursing a baby, seek the advice of a health care professional
before using this product. Keep this and all medications out of the reach of children. In
case of accidental overdose, seek professional assistance or contact a Poison Control Center
immediately. Protect from light and heat. TAMPER EVIDENT: Do not use this product if
tamper-evident seal on base of bottle cap is missing or broken. INGREDIENTS: 30 mL
contains: Okoubaka aubrevillei 2X in a base of purified water, ethanol (70 %). Rev. 06/2009


* Please review the disclaimer below.